Condition (MeSH)
Mastitis
ClinicalTrials.gov lists 38 trials for Mastitis or a narrower condition beneath it. Biosearch S.A. has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
25 of the 38 trials are tagged with Mastitis itself; the rest are tagged with a narrower condition beneath it.
When did Mastitis trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 4 |
| 2025 | 1 |
| 2024 | 5 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 3 |
| 2020 | 3 |
| 2019 | 5 |
| 2018 | 1 |
| 2017 | 1 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Mastitis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 3 |
| Phase 2/3 | 1 |
| Phase 4 | 3 |
| Not applicable | 13 |
| Observational | 18 |
How many Mastitis trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 6 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 18 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Mastitis trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Biosearch S.A. | 3 |
| Istanbul Training and Research Hospital | 2 |
| European Breast Cancer Research Association of Surgical Trialists | 1 |
| Gaziosmanpasa Research and Education Hospital | 1 |
| KK Women's and Children's Hospital | 1 |
Which drugs are being tested for Mastitis? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Maltodextrin | 2 |
| Lactobacillus salivarius PS2 | 2 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Anti-pyretic medication, paracetamol | 1 |
| Hydrocortisone Butyrate 0.1% Cream | 1 |
| Therapeutic Ultrasound | 1 |
| Lactobacillus fermentum LC40 | 1 |
| Lactobacillus salivarius HN6 | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Mastitis? (40)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized controlled trial. | eLife | 2023 | Yes |
| Incidence, antibiotic treatment and outcomes of lactational mastitis: Findings from The Norwegian Mother, Father and Child Cohort Study (MoBa). | Paediatric and perinatal epidemiology | 2022 | Yes |
| Interactions between human milk oligosaccharides, microbiota and immune factors in milk of women with and without mastitis. | Scientific reports | 2022 | Yes |
| Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. | Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine | 2022 | Yes |
| Oral Lactobacillus fermentum CECT5716 in the patients with lactational abscess treated by needle aspiration: The late follow-up of a randomized controlled trial. | Medicine | 2022 | Yes |
Showing 5 of 40 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.